J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors, and United Al Saqer Announce the Winner of the First Life Sciences Innovation Summit 2024

Press Release /PRNewswire/ -- Today, J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors, and United Al Saqer Group announced that the winner of the first J.P. Morgan Asset Management: Life Sciences Innovation Summit isRaees Rahmanfrom Harmonic Discovery (NASDAQ:). Harmonic Discovery is a company engaged in precision pharmacology, utilizing a generative chemistry platform to advance next-generation kinase successors. In collaboration with the Abu Dhabi Department of Health, the summit took place on May 14 and 15, 2024, at the Cleveland Clinic in Abu Dhabi, showcasing 11 innovative finalists as well as current developers and opportunities in the Emirate of Abu Dhabi.

As part of the event, there were also key presentations from speakers such as the doctor.Lori Glimcherfrom the Dana-Farber Cancer Institute, doctorShah Rukh Hashmifrom the Abu Dhabi Department of Health and doctorDavid Hofrom the Medical Center of Columbia University. Participants had the opportunity to network, which allowed them to gain valuable insights into the future of innovation in the life sciences.

“We are thrilled by the level of biotechnological enthusiasm and innovation that we witnessed at this summer summit in Abu Dhabi. The energy at the event was truly palpable,” notedSteven Squinto“Dr. Raeesa Rahman, Chief Investment Officer of J.P. Morgan Life Sciences Private Capital. 'We are pleased to announce Raeesa Rahman as the winner of our first Life Sciences Innovation Summit. The Harmonic Discovery approach embodies a new generation of drug development and discovery. We appreciate the time and effort of all participants and look forward to our next event in this region.'”

In addition, the jury awarded an honorable mention.Chun-Hao HuanAlgen Biotechnologies is a company focused on platform therapy and drug discovery, utilizing advanced CRISPR technology and artificial intelligence to find treatments for cancer, inflammatory diseases, and metabolic disorders.

The winners were selected by a respected international jury, which included:

• doctorLori Glimcher, president and CEO of the Dana-Farber Cancer Institute
• doctorJorge Guzmán, the CEO of the Cleveland Clinic in Abu Dhabi
• professorShahrukh Khurshid Khashmi, Director of Research at the Abu Dhabi Department of Health
• doctorYasmin Hayek Kobei, Executive Director of Blue Horizon Advisors
• Anya Shiessmanaging partner at J.P. Morgan Life Sciences Private Capital
• doctorWalid Zahirco-founder and CEO of Carexso

"Under the wise leadership of the UAE, Abu Dhabi is at the forefront of medical excellence, offering unprecedented opportunities to enhance healthcare quality for international partners," she commented.Doctor Asma Al Mannai“As the Executive Director of the Center for Research and Innovation at the Abu Dhabi Department of Health, it was a great honor for us to host the J.P. Morgan Asset Management Summit on Life Sciences Innovation 2024 ahead of the Global Health Week in Abu Dhabi. We congratulate the winners for their innovative work in healthcare; their commitment to innovation is not only changing the landscape of medicine but also promises to improve lives around the world.”

The event was sponsored by J.P.

An important point was that at the summit, Mr.Mohamed Al BreikiThe Executive Director for Sustainable Development at Masdar City announced that the city's free zone will provide all 11 finalists with free business licenses, thereby supporting their growth in the region. Masdar City is one of the most sustainable urban expansions and innovation hubs in the world, with a growing focus on entrepreneurship in the life sciences sector in Abu Dhabi.

"As the main sponsor, we strive to support and develop all 11 finalists in this dynamic biotechnology ecosystem," he concluded.Nabil Kobaisi“This summit marks the beginning of a transformational journey, and we are confident that it paves the way for the development of a thriving hub in the region. We are also pleased to announce our intention to invest and collaborate with the winner, Harmonic Discovery, to support its further growth in this region.”

To learn more about the finalists and the first event, please visit its dedicated website.

About J.P. Morgan Life Sciences Private Capital

J.P. Morgan Life Sciences Private Capital is a venture capital and growth team operating within J.P. Morgan Private Capital, Asset Management Alternatives, established in late 2022. The group aims to leverage the expertise of its team in life sciences investments and strategic advisors, as well as its connections with pharmaceutical and biotechnology companies, to support innovative companies in the life sciences sector.

About J.P. Morgan Asset Management

J.P. Morgan Asset Management, with assets under management of $3.2 trillion (as of March 31, 2024), is a global leader in asset management. Its clients include institutions, retail investors, and high-net-worth individuals across all major markets worldwide. J.P. Morgan Asset Management offers global asset management in equities, fixed income, real estate, hedge funds, private equity, and liquidity.

About Blue Horizon Advisors

Blue Horizon Advisors is an independent division of private investments from a leading multi-billion dollar family office in the United Arab Emirates (UAE). Blue Horizon Advisors includes top investment specialists from Europe and the UAE and engages in global strategic investments in public and private markets, as well as in real estate. Recently, Blue Horizon Advisors has established a vertical in the life sciences sector ("BHLS"), aiming to become a prominent and influential force in the thriving life sciences sector in the MENA region.